Background:
Prediction of early progression in glioblastoma may provide an opportunity to personalize treatment. Simplified intravoxel incoherent motion (IVIM) MRI offers quantitative estimates of diffusion and perfusion metrics. We investigated whether these metrics, during chemoradiation, could predict treatment outcome.
Methods:
38 patients with newly diagnosed IDH-wildtype glioblastoma undergoing 6-week/30-fraction chemoradiation had standardized post-operative MRIs at baseline (radiation planning), and at the 10th and 20th fractions. Non-overlapping T1-enhancing (T1C) and non-enhancing T2-FLAIR hyperintense regions were independently segmented. Apparent diffusion coefficient (ADC
T1C
, ADC
T2-FLAIR
) and perfusion fraction (
f
T1C
, f
T2-FLAIR
) maps were generated with simplified IVIM modelling. Parameters associated with progression before or after 6.9 months (early vs late progression, respectively), overall survival (OS) and progression-free survival (PFS) were investigated.
Results:
Higher ADC
T2-FLAIR
at baseline [Odds Ratio (OR) = 1.06, 95% CI 1.01–1.15,
p
= 0.025], lower
f
T2-FLAIR
at fraction 10 (OR = 2.11, 95% CI 1.04–4.27,
p
= 0.018), and lack of increase in ADC
T2-FLAIR
at fraction 20 compared to baseline (OR = 1.12, 95% CI 1.02–1.22,
p
= 0.02) were associated with early progression. Combining ADC
T2-FLAIR
at baseline,
f
T2-FLAIR
at fraction 10, ECOG and MGMT promoter methylation status significantly improved AUC to 90.3% compared to a model with only ECOG and MGMT promoter methylation status (
p
= 0.001). Using multivariable analysis, neither IVIM metrics were associated with OS but higher
f
T2-FLAIR
at fraction 10 (HR = 0.72, 95% CI 0.56–0.95,
p
= 0.018) was associated with longer PFS.
Conclusion:
ADC
T2-FLAIR
at baseline, its lack of increase from baseline to fraction 20, or
f
T2-FLAIR
at fraction 10 significantly predicted early progression.
f
T2-FLAIR
at fraction 10 was associated with PFS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.